longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Danaher

DHR

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfileWeekly ReviewWeekly Review
LongbridgeAI

Current ValuationThe current P/E ratio is 35.68, within the reasonable range, cheaper than 53.65% of the time in the past 5 years, and the industry ranks 10/59, the industry Median -1.56.

35.68xP/E
$203.25Stock price
$5.70Earnings per share
35.68xP/E
Stock price$203.25Earnings per share$5.70

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
36.60x
Typical range
28.64x–42.76x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
09182736

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
TMOUSThermo Fisher Scentific
32.57x13.43%$226.88B
DHRUSDanaher
35.68x17.40%$142.88B
IQVUSIQVIA
31.80x0.96%$43.73B
AUSAgilent Tech
28.74x12.34%$41.39B
ILMNUSIllumina
38.15x9.25%$31.44B
WXXWYUSWuXi Biologics
35.93x--$25.87B
MTDUSMettler Toledo
28.45x10.40%$25.76B
MEDPUSMedpace
33.81x15.09%$16.62B
QGENUSQiagen NV
21.13x0.70%$8.65B
STVNUSStevanato Group SpA
37.26x8.92%$5.82B
SHCUSSotera Health
32.33x154.32%$5.29B
BLFSUSBioLife Solutions
29.89x1,266.67%$1.73B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.